T1 and ECV Mapping in Myocardial Disease

T1 and ECV Mapping in Myocardial Disease

T1 mapping using cardiovascular magnetic resonance (CMR) introduces novel techniques for myocardial tissue characterization to detect and quantify disease processes occurring at the microscopic level. Even though T1 mapping has limited spatial resolution, cellular and molecular changes occurring wit...

Full description

Bibliographic Details
Main Authors:	Eric L. Olausson, Erik B. Schelbert, MD, MS
Format:	Article
Language:	English
Published:	Compuscript 2016-12-01
Series:	Cardiovascular Innovations and Applications
Subjects:	T1 mapping extracellular volume myocardial fibrosis remodeling amyloidosis
Online Access:	http://www.ingentaconnect.com/content/cscript/cvia/2016/00000002/00000001/art00007

Similar Items

Serial T1 mapping of right ventricle in pulmonary hypertension: comparison with histology in an animal study
by: Pan Ki Kim, et al.
Published: (2021-05-01)

Importance of standardizing timing of hematocrit measurement when using cardiovascular magnetic resonance to calculate myocardial extracellular volume (ECV) based on pre- and post-contrast T1 mapping
by: Henrik Engblom, et al.
Published: (2018-06-01)

Myocardial Fibrosis Quantified by Extracellular Volume Is Associated With Subsequent Hospitalization for Heart Failure, Death, or Both Across the Spectrum of Ejection Fraction and Heart Failure Stage
by: Erik B. Schelbert, et al.
Published: (2015-12-01)

Cardiac MRI T1 mapping and extracellular volume application in hypertrophic cardiomyopathy
by: Nahla D. Ali, et al.
Published: (2021-02-01)

Native T1 mapping and extracellular volume fraction for differentiation of myocardial diseases from normal CMR controls in routine clinical practice
by: Rawiwan Thongsongsang, et al.
Published: (2021-06-01)

T1- and ECV-mapping in clinical routine at 3 T: differences between MOLLI, ShMOLLI and SASHA
by: Julius F. Heidenreich, et al.
Published: (2019-08-01)

Association between myocardial extracellular volume and strain analysis through cardiovascular magnetic resonance with histological myocardial fibrosis in patients awaiting heart transplantation
by: Yue Cui, et al.
Published: (2018-04-01)

Age and Gender Impact the Measurement of Myocardial Interstitial Fibrosis in a Healthy Adult Chinese Population: A Cardiac Magnetic Resonance Study
by: Yang Dong, et al.
Published: (2018-03-01)

Age and sex corrected normal reference values of T1, T2 T2* and ECV in healthy subjects at 3T CMR
by: Clotilde Roy, et al.
Published: (2017-09-01)

The impact of Wilson disease on myocardial tissue and function: a cardiovascular magnetic resonance study
by: Janek Salatzki, et al.
Published: (2021-06-01)

Myocardial Fibrosis in Heart Failure: Anti-Fibrotic Therapies and the Role of Cardiovascular Magnetic Resonance in Drug Trials
by: Matthew Webber, et al.
Published: (2020-08-01)

A prospective study examining the role of myocardial Fibrosis in outcome following mitral valve repair IN DEgenerative mitral Regurgitation: rationale and design of the mitral FINDER study
by: Boyang Liu, et al.
Published: (2017-11-01)

Quantitative cardiovascular magnetic resonance: extracellular volume, native T1 and 18F-FDG PET/CMR imaging in patients after revascularized myocardial infarction and association with markers of myocardial damage and systemic inflammation
by: Karl P. Kunze, et al.
Published: (2018-05-01)

Relationship between CMR-derived parameters of ischemia/reperfusion injury and the timing of CMR after reperfused ST-segment elevation myocardial infarction
by: Pier-Giorgio Masci, et al.
Published: (2018-07-01)

Myocardial fibrosis: Current aspects of the problem
by: V N Karetnikova, et al.
Published: (2017-01-01)

Increased myocardial extracellular volume assessed by cardiovascular magnetic resonance T1 mapping and its determinants in type 2 diabetes mellitus patients with normal myocardial systolic strain
by: Yukun Cao, et al.
Published: (2018-01-01)

Т1 mapping in the evaluation of the risk factors for diffuse myocardial fibrosis in essential arterial hypertension
by: A. S. Abramenko, et al.
Published: (2020-12-01)

Metformin Attenuates Postinfarction Myocardial Fibrosis and Inflammation in Mice
by: Halyna Loi, et al.
Published: (2021-08-01)

The effect of beta-blockade on myocardial remodelling in Chagas' cardiomyopathy
by: Walace de Souza Pimentel, et al.
Published: (2012-09-01)

Could native T1 mapping replace late gadolinium enhancement in the assessment of myocardial fibrosis in patients with cardiomyopathy?
by: Hend G Elsafty, et al.
Published: (2021-09-01)

Does Transient Receptor Potential Vanilloid Type 1 Alleviate or Aggravate Pathological Myocardial Hypertrophy?
by: Qiqi Yan, et al.
Published: (2021-05-01)

The Non-Fibrillar Side of Fibrosis: Contribution of the Basement Membrane, Proteoglycans, and Glycoproteins to Myocardial Fibrosis
by: Michael Chute, et al.
Published: (2019-09-01)

MECHANISMS FOR THE FORMATION MYOCARDIAL FIBROSIS IN NORM AND IN CERTAIN CARDIOVASCULAR DISEASES, HOW TO DIAGNOSE IT
by: S. V. Miklishanskaya, et al.
Published: (2017-11-01)

Volume Load-Induced Right Ventricular Failure in Rats Is Not Associated With Myocardial Fibrosis
by: Quint A. J. Hagdorn, et al.
Published: (2021-02-01)

T1-Mapping and extracellular volume estimates in pediatric subjects with Duchenne muscular dystrophy and healthy controls at 3T
by: Nyasha G. Maforo, et al.
Published: (2020-12-01)

T 1 mapping performance and measurement repeatability: results from the multi-national T 1 mapping standardization phantom program (T1MES)
by: Gabriella Captur, et al.
Published: (2020-05-01)

Rare Disease: Cardiac Risk Assessment With MRI in Patients With Myotonic Dystrophy Type 1
by: Marco Alì, et al.
Published: (2020-03-01)

Myocardial fibrosis in asymptomatic and symptomatic chronic severe primary mitral regurgitation and relationship to tissue characterisation and left ventricular function on cardiovascular magnetic resonance
by: Boyang Liu, et al.
Published: (2020-12-01)

Guanxinshutong capsule ameliorates cardiac function and architecture following myocardial injury by modulating ventricular remodeling in rats
by: Jiaqi Zhu, et al.
Published: (2020-10-01)

Tongguan capsule derived-herb ameliorates remodeling at infarcted border zone and reduces ventricular arrhythmias in rats after myocardial infarction
by: Shiyu Ma, et al.
Published: (2019-12-01)

Myocardial fibrosis in patients with a history of Kawasaki disease
by: Susan M. Dusenbery, et al.
Published: (2021-02-01)

Assessment of reverse remodeling predicted by myocardial deformation on tissue tracking in patients with severe aortic stenosis: a cardiovascular magnetic resonance imaging study
by: Ji-won Hwang, et al.
Published: (2017-10-01)

Magnetic Resonance Imaging in Myocardial Fibrosis Related to Ischemic Events
by: Himcinschi Elisabeta, et al.
Published: (2017-09-01)

Comparison of short axis and long axis acquisitions of T1 and extracellular volume mapping using MOLLI and SASHA in patients with myocardial infarction and healthy volunteers
by: Christos G. Xanthis, et al.
Published: (2019-02-01)

Left ventricular function recovery in peripartum cardiomyopathy: a cardiovascular magnetic resonance study by myocardial T1 and T2 mapping
by: Yao-Dan Liang, et al.
Published: (2020-01-01)

Assessment of Myocardial Fibrosis in Hypertrophic Cardiomyopathy by Cardiac Magnetic Resonance: Modalities and Clinical Applications.
by: Carla Contaldi
Published: (2016-01-01)

Electrocardiogram-less, free-breathing myocardial extracellular volume fraction mapping in small animals at high heart rates using motion-resolved cardiovascular magnetic reesonance multitasking: a feasibility study in a heart failure with preserved ejection fraction rat model
by: Pei Han, et al.
Published: (2021-02-01)

Myocardial native T2 measurement to differentiate light-chain and transthyretin cardiac amyloidosis and assess prognosis
by: Fourat Ridouani, et al.
Published: (2018-08-01)

T1 mapping of the myocardium: Intra-individual assessment of the effect of field strength, cardiac cycle and variation by myocardial region
by: Kawel Nadine, et al.
Published: (2012-05-01)

Left atrial volume index as a predictor of left ventricular remodeling in patients with anterior STEMI treated with primary PCI
by: Mohamed Naseem, et al.
Published: (2016-03-01)